Does UMECLIDINIUM Cause Bronchial secretion retention? 83 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Bronchial secretion retention have been filed in association with UMECLIDINIUM (Anoro Ellipta). This represents 1.3% of all adverse event reports for UMECLIDINIUM.
83
Reports of Bronchial secretion retention with UMECLIDINIUM
1.3%
of all UMECLIDINIUM reports
0
Deaths
80
Hospitalizations
How Dangerous Is Bronchial secretion retention From UMECLIDINIUM?
Of the 83 reports, 80 (96.4%) required hospitalization, and 55 (66.3%) were considered life-threatening.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMECLIDINIUM. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does UMECLIDINIUM Cause?
Dyspnoea (1,817)
Asthma (1,433)
Wheezing (1,111)
Therapeutic product effect incomplete (980)
Cough (913)
Drug ineffective (734)
Loss of personal independence in daily activities (711)
Obstructive airways disorder (654)
Chronic obstructive pulmonary disease (588)
Condition aggravated (580)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
Which UMECLIDINIUM Alternatives Have Lower Bronchial secretion retention Risk?
UMECLIDINIUM vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMECLIDINIUM vs UMIFENOVIR
UMECLIDINIUM vs UNSPECIFIED INGREDIENT
UMECLIDINIUM vs UPADACITINIB
UMECLIDINIUM vs URAPIDIL